obsidian-integrative-health-and-wellness-llc

PCOS Is Now PMOS: What the New Name Means for Metabolic Health

Sun, 31 May 2026 02:22:14 GMT

PCOS Is Now PMOS: What the New Name Means for Metabolic Health

Polycystic Ovary Syndrome, commonly known as PCOS, has been renamed Polyendocrine Metabolic Ovarian Syndrome, or PMOS. The Endocrine Society announced the name change in May 2026, describing PMOS as the new name for a condition affecting about 1 in 8 women worldwide.

This change matters because the old name placed too much attention on 'cysts,' even though ovarian cysts are not the full story. PMOS better reflects what many patients and clinicians already understand: this condition can involve multiple hormone systems, insulin resistance, weight changes, blood sugar patterns, cholesterol concerns, skin symptoms, menstrual cycle changes, fertility concerns, and long-term cardiometabolic risk.

At Obsidian Integrative Health & Wellness, we focus on the metabolic side of PMOS. Our goal is to help patients better understand how symptoms, labs, lifestyle patterns, weight history, and cardiometabolic risk may be connected

Why the Name Changed

The term 'Polycystic Ovary Syndrome' suggested that ovarian cysts were the defining feature of the condition. That was misleading. Some patients with PCOS/PMOS do not have ovarian cysts, and the condition can affect much more than the ovaries. The new name highlights the broader endocrine and metabolic features of the syndrome. 'Polyendocrine' reflects that multiple hormone systems may be involved. 'Metabolic' recognizes the role of insulin resistance, blood sugar regulation, weight patterns, lipids, and long-term cardiometabolic health. 'Ovarian' remains in the name because reproductive and menstrual-cycle symptoms can still be part of the condition.The term 'Polycystic Ovary Syndrome' suggested that ovarian cysts were the defining feature of the condition. That was misleading. Some patients with PCOS/PMOS do not have ovarian cysts, and the condition can affect much more than the ovaries. The new name highlights the broader endocrine and metabolic features of the syndrome.

'Polyendocrine' reflects that multiple hormone systems may be involved. 'Metabolic' recognizes the role of insulin resistance, blood sugar regulation, weight patterns, lipids, and long-term cardiometabolic health. 'Ovarian' remains in the name because reproductive and menstrual-cycle symptoms can still be part of the condition.

Why PMOS Is More Than a Reproductive Condition

PMOS may involve irregular menstrual cycles, acne, excess hair growth, hair thinning, fertility concerns, and androgen-related symptoms. But it can also involve metabolic concerns such as insulin resistance, prediabetes risk, weight changes, elevated triglycerides, low HDL cholesterol, fatty liver risk, and long-term cardiovascular risk.

The 2023 international evidence-based guideline for PCOS emphasized the importance of lifelong metabolic screening and cardiovascular risk-factor assessment for people with PCOS, which supports a whole-person approach to care.

The Role of Insulin Resistance

Insulin helps move glucose from the bloodstream into cells for energy. In insulin resistance, the body has a harder time using insulin effectively. As a result, the pancreas may produce more insulin to compensate. For many patients with PMOS, insulin resistance can contribute to hunger, cravings, weight gain or difficulty losing weight, blood sugar changes, and androgen-related symptoms. High insulin levels may also influence ovarian hormone signaling and contribute to symptoms such as acne, excess hair growth, and irregular cycles. This is why metabolic evaluation matters. Looking only at weight or reproductive symptoms can miss the bigger picture.

What We May Review at Obsidian

During a comprehensive metabolic assessment, we may review:

Weight and waist trends
Appetite, cravings, and satiety patterns
Menstrual-cycle history and symptom patterns
A1C, fasting glucose, and insulin trends when appropriate
Cholesterol and triglycerides
Liver and kidney markers
Thyroid markers when appropriate
Medication and supplement history
Sleep, stress, nutrition, and movement patterns
Family history of diabetes, heart disease, or metabolic conditions Testing recommendations are individualized and based on your history, symptoms, goals, risk factors, and clinical needs.

Our Role in PMOS-Related Metabolic Support

Obsidian does not replace OB-GYN, endocrinology, dermatology, fertility care, or primary care. Instead, we focus on the metabolic health side of PMOS.

Our approach may include metabolic risk review, lab interpretation, lifestyle and nutrition planning, medication review, body composition testing when appropriate, education, accountability, and care coordination when needed.

For reproductive health, fertility treatment, pelvic concerns, or complex hormonal symptoms, we encourage appropriate care with an OB-GYN, endocrinologist, fertility specialist, dermatologist, or primary care clinician.

What this means for patients

The shift from PCOS to PMOS may help patients feel more seen. It recognizes that this condition is not only about ovaries, cysts, or fertility. It is also about hormones, metabolism, long-term health, and quality of life. If you were previously diagnosed with PCOS, the name change does not mean your experience was wrong. It means the language is catching up to the complexity of the condition. If you suspect PMOS may be affecting your weight, energy, blood sugar, cholesterol, cravings, cycle patterns, or long-term metabolic health, a comprehensive metabolic assessment can help you better understand the full picture.

Our Role in PMOS-Related Metabolic Support

PMOS is complex, but your care plan should not be based on guesswork.

At Obsidian Integrative Health & Wellness, we help patients connect the dots between symptoms, labs, lifestyle patterns, and long-term metabolic risk.

Book your Comprehensive Metabolic Assessment to begin with a deeper, more personalized look at your metabolic health

7 Common GLP - 1 Medication Mistakes and How to Protect Your Muscle

Sun, 31 May 2026 01:45:23 GMT

7 Common GLP-1 Medication Mistakes and How to Protect Your Muscle

GLP-1 and related medications, including semaglutide and tirzepatide, have changed the way clinicians support weight-related and metabolic health concerns. These medications may help reduce appetite, improve blood sugar regulation, and support meaningful weight loss when used appropriately as part of a broader care plan. But medication alone is not the full plan. When weight loss happens too quickly or without enough nutrition, resistance training, hydration, and monitoring, some patients may lose more lean mass than intended.

The goal is not simply to see the scale go down. The goal is to support fat loss while protecting strength, function, metabolic health, and long-term sustainability.

At Obsidian Integrative Health & Wellness, we focus on thoughtful medication evaluation, patient education, and metabolic preservation. Here are seven common mistakes patients should avoid when using GLP-1 or related medications.

Mistake 1: Not Eating Enough Protein

GLP-1 medications often reduce appetite. For many patients, that is part of why the medication helps. But a lower appetite can also make it harder to eat enough protein. Protein matters because it helps support lean tissue, immune function, recovery, and satiety. When intake is too low during weight loss, the body may lose more lean mass along with fat mass. What to do instead: Prioritize protein at meals and snacks. Many patients benefit from discussing a personalized protein goal with their clinician, especially if they have kidney disease, digestive concerns, or other medical conditions. Protein targets should be individualized based on health status, goals, and activity level.

Mistake 2: Skipping Strength Training

Walking and general movement are valuable, but they are not enough by themselves for muscle preservation. Resistance training gives the body a signal to maintain muscle during weight loss. This can include weights, resistance bands, body-weight exercises, or supervised strength-based movement. What to do instead: Aim to include resistance training several times per week, as tolerated and appropriate for your fitness level. Patients with pain, mobility limitations, heart disease, or other medical concerns should seek individualized guidance before starting a new exercise plan.

Mistake 3: Treating Medication Like a Standalone Plan GLP-1 medications can reduce hunger and food noise, but they do not automatically build sustainable habits. If nutrition quality, meal timing, protein, fiber, sleep, stress, hydration, and movement are ignored, the medication may help the scale move without improving the full metabolic picture. What to do instead: Use the medication as a tool that makes it easier to build healthier routines. Focus on whole foods, adequate protein, fiber-rich vegetables, hydration, and realistic meal planning. This is especially important because reduced intake can increase the risk of nutritional gaps if food choices are limited.

Mistake 4: Ignoring Hydration and Electrolytes

Some patients eat and drink less on GLP-1 medications because appetite and thirst cues may change. Nausea, constipation, and lower intake can also make hydration more difficult. Dehydration can contribute to fatigue, dizziness, headaches, constipation, and feeling unwell. What to do instead: Build a hydration routine instead of waiting until you feel thirsty. Water needs vary based on body size, medications, kidney function, activity level, climate, and medical conditions. Some patients may also need attention to electrolytes, but this should be individualized, especially for anyone with kidney disease, heart failure, hypertension, or patients taking diuretics.

Mistake 5: Only Tracking the Scale

The scale cannot tell whether weight loss is coming from fat mass, lean mass, fluid shifts, or a combination. This matters because preserving lean mass helps support strength, mobility, glucose regulation, and long-term metabolic health. Research reviews have noted that lean mass loss can occur during weight loss with GLP-1 therapies, which is why monitoring and lifestyle support are important. What to do instead: Track more than body weight. When appropriate, this may include waist measurements, strength, energy, lab trends, body composition testing, nutrition intake, side effects, and how well the plan fits your life. At Obsidian, body composition testing such as DEXA or other validated tools may be discussed when clinically appropriate to help patients better understand fat mass, lean mass, and progress over time.

Mistake 6: Increasing the Dose Too Quickly

More medication is not always better. Some patients feel pressure to increase quickly, but higher doses may increase side effects such as nausea, vomiting, constipation, reflux, or poor intake. If side effects make it difficult to eat enough protein, hydrate, or function well, the plan may need to be adjusted. What to do instead: Use the lowest effective dose that supports meaningful progress and tolerability. Dose decisions should be individualized and made with a qualified clinician based on response, side effects, goals, medication access, medical history, and safety.

Mistake 7: Neglecting Sleep and Stress

Metabolism does not exist in isolation. Poor sleep and chronic stress can affect appetite, cravings, glucose regulation, blood pressure, energy, and recovery. Even with medication support, patients may struggle if sleep and stress are not addressed. What to do instead: Prioritize sleep, recovery, and stress-management routines. This does not have to be complicated. A consistent bedtime, reduced evening screen time, light movement, breathing exercises, and realistic boundaries can all support the broader metabolic plan.

A Safer, More Complete GLP-1 Plan

GLP-1 medications can be helpful, but they should be used thoughtfully. A strong plan should include:

Clinical evaluation before starting medication
Review of health history, medications, contraindications, and risks
Nutrition support, including adequate protein
Strength training and movement planning
Hydration and side effect management
Lab monitoring when appropriate
Body composition review when appropriate
Ongoing follow-up and adjustment Medication should support your health, not replace the foundation of your care.

Important Note About Medication Safety

Obsidian prioritizes patient safety, clinical appropriateness, and transparent medication counseling. FDA-approved medications are preferred when clinically appropriate and accessible.

In limited situations, a compounded medication may be considered when the clinician determines it is appropriate for an individual patient's clinical needs. Compounded medications are not FDA-approved and are not represented as equivalent to FDA-approved medications.

Obsidian does not encourage patients to purchase GLP-1 medications from unverified online sources, products labeled "research use only," or products not intended for human use.

Take the First Step

If you are considering GLP-1 medication or already using one, the goal should be more than weight loss. The goal should be safer, stronger, and more sustainable metabolic progress. At Obsidian Integrative Health & Wellness, we help patients evaluate whether medication support is appropriate, monitor progress, protect lean mass, and build a care plan that supports long-term health.

Book your Comprehensive Metabolic Assessment to begin with a deeper look at your metabolic health, body composition, labs, lifestyle patterns, and medication options.

Metabolic Health basics

Wed, 06 May 2026 19:05:45 GMT

What is Metabolic Health, and Why Should You Care?

You have probably heard the word "metabolism" a hundred times. Maybe tied to weight loss, or energy, or why your friend can eat anything and not gain a pound. But metabolic health is something much bigger than that, and most people have no idea how much it affects every system in their body.

Here is the honest truth: most American adults are not metabolically healthy. Not most. Research published in Metabolic Syndrome and Related Disorders found that only about 12 percent of American adults meet all five criteria for optimal metabolic health. That means roughly 88 percent of us are walking around with at least one metabolic risk factor, often without any symptoms, and often without being told.

So what does metabolic health actually mean?

The Five Markers of Metabolic Health

Clinicians generally assess metabolic health by looking at five key measurements:

Blood sugar (fasting glucose below 100 mg/dL, or HbA1c below 5.7%)
Blood pressure (below 120/80 mmHg)
Triglycerides (below 150 mg/dL)
HDL cholesterol (above 40 mg/dL in men, above 50 mg/dL in women)
Waist circumference (below 40 inches in men, below 35 inches in women)

To be considered metabolically healthy, you ideally want all five in optimal range, without needing medication to get them there. That last part matters. A controlled blood pressure on three medications is still a metabolically at-risk blood pressure.

Why Your Metabolism Affects More Than Your Weight

Your metabolism is not just about burning calories. It is the entire set of chemical processes your body uses to produce energy, regulate hormones, repair cells, manage inflammation, and keep your organs running. When metabolic dysfunction sets in, it does not stay in one lane. It touches nearly everything.

Insulin resistance, one of the earliest signs of metabolic trouble, is directly linked to increased risk of type 2 diabetes, heart disease, fatty liver disease, polycystic ovarian syndrome, cognitive decline, and even certain cancers. The common thread in all of these conditions is not bad luck. It is a metabolic system under chronic strain.

What Causes Metabolic Dysfunction?

The usual suspects are real: poor diet, physical inactivity, chronic sleep deprivation, and prolonged stress. But the picture is more nuanced than "eat less, move more." Research has identified chronic low-grade inflammation, gut microbiome disruption, environmental toxins, and even social isolation as contributors to metabolic disease.

The important thing to understand is that metabolic dysfunction develops silently, over years, before it shows up on a standard lab panel. By the time fasting glucose hits the prediabetes range, insulin resistance has often been present for a decade.

The Good News

Metabolic dysfunction is largely reversible in its early and middle stages. Unlike some health conditions where damage is fixed, the metabolic system is remarkably responsive to targeted lifestyle change, and in some cases, well-chosen clinical support. The key is catching it early and addressing the root causes, not just managing the numbers.

That is exactly what integrative metabolic care is designed to do.

Insulin Resistance & Prediabetes

Wed, 06 May 2026 19:05:44 GMT

The Silent Alarm: Understanding Insulin Resistance and Prediabetes Before They Become Diabetes

If you have been told your blood sugar is "a little high" or that you are "borderline," you may have walked out of that appointment feeling fine. After all, you do not have diabetes yet, right?

Here is what that conversation often leaves out: prediabetes and insulin resistance are not a waiting room for diabetes. They are active, treatable conditions that carry real risk right now, and they are far more common than most people realize.

How Many People Are Affected?

According to data cited by the National Institutes of Health in 2025, approximately 1 in every 3 adults in the United States has prediabetes. Nearly 80 percent of them do not know it. Globally, research published in Diabetes Care in 2025 confirms the numbers are similarly alarming across most high-income countries.

Insulin resistance, the metabolic condition that drives prediabetes, is even more widespread. A 2025 systematic review and meta-analysis published in Frontiers in Endocrinology estimated global insulin resistance prevalence at approximately 26.5 percent of the adult population. Among U.S. adults aged 18 to 44, NHANES-based data places the figure closer to 40 percent.

These are not marginal numbers. This is a population-level metabolic crisis happening largely below the surface

What is Insulin Resistance, Really?

Insulin is the hormone your pancreas releases to help your cells absorb glucose from the bloodstream and use it for energy. When cells stop responding to insulin efficiently, the pancreas compensates by producing more and more of it. Blood glucose stays relatively normal for a while, so standard labs look okay, but insulin levels are elevated and the system is under strain.

Over time, the pancreas cannot keep up. Blood glucose starts to rise into the prediabetes range (fasting glucose between 100 and 125 mg/dL, or HbA1c between 5.7 and 6.4%). Left unaddressed, it crosses into type 2 diabetes territory.

But here is what most patients are not told: the window between insulin resistance and prediabetes, and even early type 2 diabetes, is a powerful opportunity for intervention. This is not a conveyor belt you have to ride.

What Are the Warning Signs?

Insulin resistance does not usually announce itself with dramatic symptoms. It tends to be subtle:

Persistent fatigue, especially after meals
Difficulty losing weight despite effort
Sugar and carbohydrate cravings
Brain fog
Elevated fasting triglycerides or low HDL on routine labs
Darkened skin patches in skin folds (acanthosis nigricans)
Abdominal weight gain even with stable overall weight

None of these alone confirms insulin resistance, but together they are a signal worth taking seriously and worth checking with proper lab work.

What Can Actually Be Done?

The evidence on this point is strong and worth stating clearly. The Diabetes Prevention Program, a landmark NIH-funded trial, showed that intensive lifestyle intervention reduced progression from prediabetes to type 2 diabetes by 58 percent over three years. That outperformed metformin, which reduced progression by 31 percent.

A review published in IntechOpen in 2024 confirms that whole food dietary approaches, structured movement, and stress reduction each independently improve insulin sensitivity through distinct mechanisms: improving mitochondrial function, reducing systemic inflammation, modulating the gut microbiome, and lowering cortisol-driven glucose dysregulation.

This is not about willpower. It is about addressing the biological drivers with a plan that makes sense for your actual life.

Cardiometabolic Risk

Wed, 06 May 2026 19:05:43 GMT

Your Heart and Your Metabolism Are Not Separate Problems

Most people think of heart disease and blood sugar problems as separate issues. You see a cardiologist for one and an endocrinologist for the other. But your body does not organize itself by specialty, and the research is clear: metabolic dysfunction and cardiovascular disease are deeply, biologically connected.

This connection has a name: cardiometabolic risk. And understanding it could change how you think about your health.

The Numbers Behind the Connection

Cardiovascular disease remains the leading cause of death in the United States. Data from the CDC's National Vital Statistics System for 2023 shows that heart disease, stroke, diabetes, kidney disease, and liver disease together account for roughly 50 percent of annual U.S. deaths, or approximately 1,050,000 people per year.

Meanwhile, a 2024 CDC report found that obesity prevalence among U.S. adults reached 40.3 percent during 2021 to 2023. A 2024 systematic bibliometric analysis published in PMC projected that U.S. cardiovascular disease prevalence is on track to rise from 11.3 percent to 15 percent between 2020 and 2025.

A 2024 review published in Cureus describes the intersection clearly: obesity, insulin resistance, high blood pressure, dyslipidemia, and chronic inflammation combine to create what researchers call a pro-thrombotic, pro-atherogenic, pro-inflammatory state. That is a biological environment that actively accelerates heart disease, stroke, and organ damage.

What is Metabolic Syndrome and Why Does it Matter?

Metabolic syndrome is the formal diagnosis given when a person has three or more of the five cardiometabolic risk factors together: central obesity (large waist circumference), elevated blood pressure, high fasting glucose, high triglycerides, and low HDL cholesterol.

A review published in the Journal of Clinical Endocrinology noted that metabolic syndrome is present in more than 80 percent of people with type 2 diabetes. The underlying driver in most cases is insulin resistance, which creates a cascade of hormonal and inflammatory signals that directly damage blood vessels, promote plaque buildup, and increase clotting risk.

This is not a theoretical link. It is a documented biological mechanism.

What Standard Care Often Misses

The typical clinical response to elevated cholesterol is a statin. The typical response to elevated blood pressure is an antihypertensive. These medications are important and often necessary. But they treat individual numbers, not the shared metabolic root that is driving all of them.

An integrative cardiometabolic approach asks a different question: why are all of these numbers elevated in the first place? When insulin resistance is the root driver, addressing it can simultaneously improve blood pressure, triglycerides, glucose, and inflammatory markers, rather than chasing each one separately.

What You Can Do

The evidence base for lifestyle modification in cardiometabolic risk is strong. Dietary approaches, structured movement, sleep optimization, and stress reduction have documented effects on every component of cardiometabolic risk. A 2024 integrative medicine review in the Integrative Cancer Therapies journal confirmed that combining dietary and exercise interventions with evidence-based nutritional supports produces meaningful improvements in metabolic syndrome markers.

The goal is not to avoid medication. The goal is to understand and address what your body is actually doing, so that every intervention, whether lifestyle or pharmaceutical, works as efficiently as possible.

Telehealth & Accessible Care

Mon, 04 May 2026 18:09:43 GMT

Getting Real Metabolic Care Without Driving Across Town: What Telehealth Actually Offers

One of the most common reasons people delay getting care for metabolic issues, insulin resistance, prediabetes, weight concerns, and cardiometabolic risk is not that they do not want help. It is that the logistics of getting that help are genuinely hard.

Scheduling with a specialist means weeks of waiting. Getting time off work for a midday appointment is not always possible. Driving to a clinic when you are already fatigued or overwhelmed adds another layer of friction. And for patients in rural or underserved areas, the nearest integrative or metabolic health provider may be hours away.

Telehealth changes that equation. And the evidence for its effectiveness in managing the exact conditions we treat at Obsidian Integrative Health is strong.

What the Research Says About Telehealth for Metabolic Conditions

A 2024 systematic review published in PMC by researchers examining telemedicine across patient populations found that telehealth is a "transformative tool" in chronic disease management, particularly for diabetes care. The review found significant improvements in clinical metrics including HbA1c levels, patient engagement, and access to specialized care in populations facing geographic barriers.

The CDC's Community Preventive Services Task Force has identified telehealth interventions as effective for improving medication adherence, blood pressure control, dietary behavior change, and self-management goals in patients with chronic cardiovascular and metabolic conditions.

A 2023 systematic review and meta-analysis published in the Journal of Medical Internet Research examining telehealth chronic disease management systems found improvements in quality of life, self-management, and self-efficacy across multiple chronic conditions.

What Telehealth Cannot Replace

It is worth being direct about the limits here. Telehealth visits are effective for metabolic health consultations, lab review, treatment planning, medication management, lifestyle counseling, and follow-up care. They are not a replacement for every physical examination need. If a hands-on assessment is clinically necessary, that will be communicated clearly.

For metabolic health management, which is primarily driven by laboratory data, patient history, and ongoing lifestyle and pharmacological support, virtual care is not a lesser version of in-person care. For many patients, it is actually more consistent care, because the barrier to follow-through is lower.

How It Works at Obsidian Integrative Health

Our process is straightforward. You schedule your Comprehensive Metabolic Health Assessment through our booking system. Lab work is ordered electronically and completed at a draw site near you before your appointment. Your visit takes place via secure video. You and your provider review your results together, discuss your history and goals, and build a plan that fits your life.

Follow-up visits, program check-ins, medication management, and ongoing support all happen the same way. You do not have to rearrange your entire day. You get consistent, clinician-led care from a provider who understands the metabolic picture as a whole.

Who Telehealth Metabolic Care Is Right For

If you are an adult dealing with any of the following, telehealth integrative metabolic care is a strong fit: prediabetes or recently diagnosed type 2 diabetes, insulin resistance or metabolic syndrome, unexplained weight changes or difficulty with weight management, elevated blood pressure or abnormal cholesterol, fatigue or brain fog with no clear explanation, or a family history of heart disease or diabetes and a desire to get ahead of your risk.

You do not have to be in crisis to start. In fact, the earlier you address metabolic dysfunction, the more options you have.

Integrative Metabolic Care

Mon, 04 May 2026 18:09:43 GMT

What Integrative Metabolic Care Actually Means, and Why It Is Different

If you have seen multiple providers and still do not have clear answers about why you feel the way you do, you are not alone. A lot of patients with insulin resistance, metabolic syndrome, or unexplained weight changes cycle through standard care and come away with a prescription for a single number without understanding the bigger picture.

Integrative metabolic care is not a rejection of conventional medicine. It is an expansion of it. Here is what that actually looks like in practice.

The Problem With Treating Numbers in Isolation

Standard clinical practice is built around diagnostic thresholds. Your fasting glucose is 102: you have prediabetes. Your LDL is 145: here is a statin. Your blood pressure is 135/88: here is a medication. Each number gets addressed individually, with its own clinical pathway.

But most chronic metabolic disease does not arise in isolation. Insulin resistance drives elevated triglycerides, blood pressure dysregulation, liver fat accumulation, and inflammatory changes all at the same time. Treating each finding separately while leaving the root driver untouched is like mopping the floor without turning off the faucet.

What A root Cause Approach Looks Like

An integrative metabolic assessment goes deeper than standard panels. It looks at:

Fasting insulin alongside fasting glucose, to catch insulin resistance before it shows up as abnormal blood sugar
Inflammatory markers like high-sensitivity CRP, which reflect systemic inflammation driving metabolic dysfunction
Advanced lipid fractionation, not just total LDL but particle size and number, which carry very different cardiovascular risk profiles
Hormonal patterns including cortisol, thyroid function, and in women, sex hormones that interact directly with metabolic health
Nutritional status, including vitamin D, magnesium, and B12 levels that affect insulin signaling
Sleep quality and quantity data, given the direct and well-documented relationship between sleep deprivation and insulin resistance

This is not about ordering every possible test. It is about asking the right clinical questions for your specific pattern.

The Evidence for Lifestyle as Medicine

A 2024 review published in the journal Integrative Cancer Therapies on integrative therapies in metabolic syndrome confirmed that dietary interventions (particularly whole food, anti-inflammatory approaches), structured movement, and evidence-based supplements including berberine, vitamin D, omega-3 fatty acids, and curcumin each have meaningful clinical evidence for improving metabolic markers.

A review published in PMC examined how mind-body interventions, including mindfulness-based stress reduction, lower cortisol and improve insulin sensitivity through modulation of the hypothalamic-pituitary-adrenal axis. These are not fringe claims. They are documented mechanisms backed by peer-reviewed research.

The integrative approach uses all of these tools together, calibrated to what your labs and clinical picture actually show, rather than applying them wholesale.

When Medication Fits In

Integrative care is not anti-medication. There are patients for whom metformin, GLP-1 agonists, statins, or antihypertensives are appropriate, evidence-based, and sometimes urgent tools. The difference is that in an integrative metabolic practice, medication is deployed in context. It is part of a plan, not the entire plan.

Weight Loss & Obesity

Mon, 04 May 2026 18:09:43 GMT

Why Losing Weight Is Not Just About Eating Less and Moving More

If you have tried to lose weight, stuck to a plan for weeks or months, and still felt like your body was working against you, you are not imagining it. You are also not lazy or lacking discipline. There is a real biological explanation for why traditional weight loss advice fails so many people, and it starts with understanding obesity as a metabolic disease rather than a character flaw.

What the Research Actually Shows About Obesity

Obesity is one of the most complex chronic conditions in medicine, and it is also one of the most stigmatized. But the clinical science has moved well past the simple "calories in, calories out" framework.

Data from the CDC's National Health and Nutrition Examination Survey found that adult obesity prevalence in the United States reached 40.3 percent during 2021 to 2023, with severe obesity rising to 9.7 percent. The World Obesity Atlas 2025 projects that by 2030, more than 50 percent of adult men and women globally will have a BMI over 30.

These numbers are not explained by a sudden collapse in willpower across the global population. They reflect a changing metabolic environment: ultra-processed food supply, chronic sleep deprivation, stress physiology, gut microbiome disruption, endocrine disruptors in the environment, and a healthcare system that still largely treats obesity as a lifestyle choice rather than a medical condition.

The Role of Insulin Resistance in Weight Gain

One of the most important and least-discussed mechanisms behind stubborn weight gain is insulin resistance. When cells stop responding to insulin efficiently, the body secretes more and more of it. Chronically elevated insulin is a fat-storage signal. It tells your body to hold onto adipose tissue, especially in the abdomen, regardless of your caloric intake.

This is why some people can reduce calories significantly and still not lose meaningful weight: if insulin remains elevated, the metabolic environment is still oriented toward fat storage. Addressing the insulin resistance itself, not just the caloric math, is often the missing piece.

Hunger Hormones Are Real

Leptin, ghrelin, GLP-1, and other hormones that regulate hunger and satiety are disrupted in obesity. Leptin resistance, where the brain stops receiving the "I am full" signal despite adequate fat stores, is well-documented in people with metabolic obesity. This is not lack of willpower. This is a hormone signaling problem with measurable biology behind it.

This is also why newer pharmacological tools like GLP-1 receptor agonists (semaglutide, tirzepatide) have shown significant efficacy in obesity treatment: they work by restoring some of the hormonal signaling that obesity disrupts. They are tools, not magic, and they work best in the context of a comprehensive metabolic health plan.

A Better Framework for Weight and Health

A meaningful metabolic weight loss approach asks: what is driving this weight gain biologically? It looks at insulin resistance markers, inflammatory patterns, cortisol and sleep data, thyroid function, gut health signals, and dietary patterns, rather than prescribing a generic calorie deficit.

Not every person with a high BMI has the same metabolic picture. And not every person who loses weight has improved their metabolic health. The goal is to improve the underlying biology, and weight changes tend to follow.